Infection activity in travelers and migrants with chronic schistosomiasis
Part of Immune system & allergy, Infections, Lungs & breathing clinical trials.
This trial looks at how active a long-term schistosomiasis infection is in travelers and migrants. It aims to better understand the infection to help guide treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have chronic schistosomiasis (infection lasting more than 3 months after last possible exposure), diagnosed by your doctor's usual methods.
- You must sign a consent form (or have a parent or guardian sign if you are a minor).
- You must be at least 5 years old.
- You cannot have taken praziquantel (a drug for schistosomiasis) after your last possible exposure to the parasite.
- You cannot have an acute (recent) infection, meaning your infection must have started more than 3 months ago.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving treatment for schistosomiasis (a parasite infection) more often helps reduce liver scarring (fibrosis). It compares different schedules of medication to see which works best and may improve liver health.
This study looks at a parasitic infection called schistosomiasis (also known as snail fever) that can affect the female genital area. It aims to learn more about this condition in women who have moved from sub-Saharan Africa, which may help improve diagnosis and care.
This study looks at whether a more precise DNA-based test can better find and confirm schistosomiasis (a parasite infection) compared to standard methods. It may help you get a clearer diagnosis and more targeted care.
This study tests whether giving preventive medicine to people who move or migrate can help control river blindness and lymphatic filariasis. It focuses on children and household heads who have missed past treatment rounds.
This study looks at how well the right side of your heart works with the blood vessels in your lungs. It focuses on people who have both schistosomiasis (a parasitic infection) and high blood pressure in the lungs, to help doctors better understand and treat this condition.
This study tests a new medicine called arpraziquantel to treat schistosomiasis (a disease from parasites in water) in young children aged 2 to 5. It aims to see if giving this treatment in communities where the disease is common is safe and helpful.
Hear when a new Schistosomiasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.